Cerca del 40% de los ensayos clínicos desarrollados en España en 2025 se destinan al cáncer

Cerca del 40% de los ensayos clínicos desarrollados en España en 2025 se destinan al cáncer  Servimedia


13 h. ago
Science
ID: -27845233917902004


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Real Estate
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Military
Science
Science
Science
Technology
Science
Science
Science
Science
Education
Science
Science
Science
Science
Crime
Science
Science
Science
Science
Science
Science
Education
Politics
Science
Science
Science
Science
Science
Science
Technology
Science
Politics
Science
Science
Science
Military
Education
Technology
Science
Science
Science
Science
Science
Science
Technology
Science
Military
Science
Science
Science
Education
Science
Space
Technology
Science
Science
Economics
US
Add Watch Country

arrow_drop_down